MON-491 Persistent Isolated Hypophosphatemia after Intravenous Ferric Carboxymaltose Infusion in a Patient with Total Gastrectomy

Introduction: Intravenous ferric carboxymaltose infusion has been reported by the FDA to cause hypophosphatemia in 2.1% of patients, with transient low phosphorus level (

Saved in:
Bibliographic Details
Published in:Journal of the Endocrine Society 2019-04, Vol.3 (Supplement_1)
Main Authors: Bailey, Rosemary, Del Castillo, Ma. Dolores, Muppavarapu, Sangeetha, Siegel, Richard, Vercollone, Jeffrey
Format: Article
Language:English
Subjects:
Bone and Mineral Metabolism
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Intravenous ferric carboxymaltose infusion has been reported by the FDA to cause hypophosphatemia in 2.1% of patients, with transient low phosphorus level (
ISSN:2472-1972
2472-1972
DOI:10.1210/js.2019-MON-491